1、Designation: E1262 88 (Reapproved 2018)Standard Guide forPerformance of Chinese Hamster Ovary Cell/HypoxanthineGuanine Phosphoribosyl Transferase Gene Mutation Assay1This standard is issued under the fixed designation E1262; the number immediately following the designation indicates the year oforigi
2、nal adoption or, in the case of revision, the year of last revision. A number in parentheses indicates the year of last reapproval. Asuperscript epsilon () indicates an editorial change since the last revision or reapproval.1. Scope1.1 This guide highlights some of the more relevant bio-logical conc
3、epts as they are currently understood, and summa-rizes the critical technical aspects for acceptable bioassayperformances as they currently are perceived and practiced.The Chinese hamster ovary cell/hypoxanthine guanine phos-phoribosyl transferase (CHO/HGPRT) assay (1)2has beenwidely applied to the
4、toxicological evaluation of industrial andenvironmental chemicals.1.2 This guide concentrates on the practical aspects of cellculture, mutagenesis procedures, data analysis, quality control,and testing strategy. The suggested approach represents aconsensus of the panel members for the performance of
5、 theassay. It is to be understood, however, that these are merelygeneral guidelines and are not to be followed without the useof sound scientific judgement. Users of the assay shouldevaluate their approach based on the properties of the sub-stances to be tested and the questions to be answered.1.3 D
6、eviation from the guidelines based on sound scientificjudgement should by no means invalidate the results obtained.1.4 The values stated in SI units are to be regarded asstandard. No other units of measurement are included in thisstandard.1.5 This standard does not purport to address all of thesafet
7、y concerns, if any, associated with its use. It is theresponsibility of the user of this standard to establish appro-priate safety, health, and environmental practices and deter-mine the applicability of regulatory limitations prior to use.1.6 This international standard was developed in accor-dance
8、 with internationally recognized principles on standard-ization established in the Decision on Principles for theDevelopment of International Standards, Guides and Recom-mendations issued by the World Trade Organization TechnicalBarriers to Trade (TBT) Committee.2. Significance and Use2.1 The CHO/HG
9、PRT assay detects forward mutations ofthe X-linked hypoxanthine-guanine phosphoribosyl transferase(hgprt) locus (coding for the enzyme, HGPRT) in Chinesehamster ovary (CHO) cells. Cells originally derived fromChinese hamster ovary tissue are exposed to a test article and,following an appropriate cel
10、l culture regimen, descendants ofthe original treated population are monitored for the loss offunctional HGPRT, presumably due to mutations. Resistance toa purine analogue, 6-thioguanine (6TG) (or less desirably,8-azaguanine (8AG), is employed as the genetic marker.HGPRT catalyzes the conversion of
11、the nontoxic 6TG to itstoxic ribophosphorylated derivative. Loss of the enzyme or itsactivity therefore leads to cells resistant to 6TG.2.2 Because HGPRT is an enzyme of the purine nucleotidesalvage pathway, loss of the enzyme is not a lethal event.Different types of mutational events (base substitu
12、tions,frameshifts, deletions, some chromosomal type lesions, and soforth) should theoretically be detectable at the hgprt locus. TheCHO/HGPRT assay has been used to study a wide range ofmutagens, including radiations (2-4), and a wide variety ofchemicals (1), and complex chemical mixtures (5).3. Cha
13、racteristics of CHO Cells3.1 Different CHO cell lines/subclones are appropriate forthe CHO/HGPRTassay.The CHO-K1-BH4 cell line developedand extensively characterized by (6) is probably the mostwidely employed. The CHO(WT) cell line and its derivative,CHO-AT3-2, are used to monitor mutations at other
14、 gene lociin addition to hgprt (7, 8). While there are differences amongthe cell lines employed, a number of general characteristics arecritical for the performance of the assay:3.1.1 The cloning efficiency (CE) of the stock culturesshould not be less than 70 %. The CE of untreated or solventcontrol
15、 experimental cultures should not be less than 50 %.3.1.2 Cultures in logarithmic phase of growth should have apopulation doubling time of 12 to 16 h.3.1.3 The modal chromosome number should be 20 or 21,as is characteristic of the particular cell line/subclone used.1This guide is under the jurisdict
16、ion of ASTM Committee F04 on Medical andSurgical Materials and Devicesand is the direct responsibility of SubcommitteeF04.16 on Biocompatibility Test Methods.Current edition approved Feb. 1, 2018. Published April 2018. Originallyapproved in 1988. Last previous edition approved in 2013 as E1262 88 (2
17、013).DOI: 10.1520/E1262-88R18.2The boldface numbers in parentheses refer to the list of references at the end ofthis guide.Copyright ASTM International, 100 Barr Harbor Drive, PO Box C700, West Conshohocken, PA 19428-2959. United StatesThis international standard was developed in accordance with int
18、ernationally recognized principles on standardization established in the Decision on Principles for theDevelopment of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.13.1.4 Cultures should be free from microbial a
19、nd myco-plasma contamination.3.2 The cell properties that are critical for the assay shouldbe routinely monitored as part of the quality control regimen.Routine quality control procedures should include testing ofserum and media for each new purchase, as well as myco-plasma and karyotype checks at l
20、east once yearly, preferablyonce every three months.4. Mutagenesis Procedures4.1 The mutagenesis protocol can be divided into threephases: mutagen treatment, expression, and selection.4.2 Mutagen Treatment:4.2.1 Cell PlatingCells should be in exponential phasewhen plated for treatment. Several media
21、 (for example, HamsF12, alpha-MEM) that are known to be optimal for cell growthcan be used. Cells should be seeded at an appropriate celldensity to allow exponential growth as well as quantitation ofinduced responses. A common practice is to plate 0.5 106cells in a 25-cm2flask, or 1.5 106cells in a
22、75-cm2flask, onthe day before treatment.4.2.2 Chemical HandlingThe solubility of the test articlein an appropriate medium should be determined before treat-ment. Commonly used solvents are, in the order of preference,medium, water, dimethylsulfoxide, ethanol, and acetone.Generally, the nonaqueous so
23、lvent concentration should notexceed 1 % and should be constant for all samples. As part ofthe solubility test, an aliquot of the test chemical should beadded to the treatment medium to note any pH changes, thepresence of any chemical precipitation, and any apparentreaction of the chemical or solven
24、t with the culture vessel. Thesolvent of choice should not have any undesirable reactionswith the test article, culture vessel, or cells.4.2.3 Addition of Test Article to CellsStock solutions ofthe test samples are prepared and aliquots are added to eachflask. Dilutions of the test article should be
25、 such that theconcentration of solvent remains constant for all samples. Cellsare generally treated with the test article for at least 3 h. Fortreatment times of 3 to 5 h, serum-free medium can be used.Asserum is required to maintain cell division, medium containingserum should be used for a prolong
26、ed treatment period (forexample, 16 h or longer). Serum requirement for treatmentperiods between 5 and 16 h should be determined on acase-by-case basis.4.2.4 Exogenous Activation SystemsAroclor 1254-induced rat liver homogenate (S9) is the most commonly usedexogenous metabolic activating system for
27、the assay. When S9is used, cofactors for the mixed function monooxygenasesshould be present. Calcium chloride (CaCl2), which enhancesthe mutagenicity of nitrosamines and polycyclic hydrocarbons(9, 10), appears to be another useful addition. However, theneed for CaCl2has yet to be documented for a wi
28、de variety ofchemicals. A commonly used cofactor mixture consists ofsodium phosphate (50 mM, pH 7.0 to 8.0), NADP (4 mM),glucose-6-phosphate (5 mM), potassium chloride (30 mM),magnesium chloride (10 mM), and CaCl2(10 mM). S9 is addeddirectly to the cofactor mixture. One volume of the S9/cofactormixt
29、ure is added to 4 volumes of the treatment medium. Otherexogenous systems (for example, hepatocytes, S9 from otheranimal species or produced using different enzyme inductionconditions, and other cofactor mixtures) can also be useddepending on the intent of the experiment.4.2.5 Estimation of Cytotoxi
30、cityPlating CHO cells imme-diately after treatment for cytotoxicity determination is gener-ally expected to yield the most accurate results. Otherwise,cytotoxicity can be estimated on the day after treatment.Aliquots of the cells are plated to allow for colony develop-ment. Cytotoxicity is usually e
31、xpressed as relative CE which isthe ratio of the CE of the treated cells to that of the solventcontrol. Viability determination should take into account anyloss of cells during the treatment period, cell trypsinizationprocedures, and the overnight incubation period.4.2.6 Positive and Solvent Control
32、sAn appropriate nega-tive control is treatment of cells with the solvent used for thetest article. Positive controls, both direct-acting and indirect-acting, should also be included to demonstrate the adequacy ofthe experimental conditions to detect known mutagens. Anuntreated control may also be in
33、cluded to evaluate the effectsof the solvent on mutagenicity. Commonly used positivecontrols are ethyl methane sulfonate (EMS) and N-methyl-N-nitro-N-nitrosoguanidine (MNNG) as direct-acting mutagens,and benzo(a)pyrene (BaP) and dimethylnitrosamine (DMN) aspromutagens that require metabolic activati
34、on.4.3 Expression of Induced Mutations:4.3.1 After mutation at the hgprt locus, the mutant pheno-type requires a period of time before it is completely expressed(expression requires the loss of pre-existing enzyme activity).Phenotypic expression is presumably achieved by dilution ofthe pre-existing
35、HGPRT enzyme and mRNA through celldivision and macromolecular turnover. At the normal popula-tion doubling times of 12 to 16 h for CHO cells, an expressionperiod of 7 to 9 days is generally adequate (11, 12).4.3.2 The most widely employed method for phenotypicexpression allows exponential growth of
36、the cells for a definedtime period after mutagen treatment. CHO cells can besubcultured with 0.05 % trypsin with or without EDTA.Aliquots of 1 106cells are subcultured at 2 or 3 day intervalsin 100-mm diameter tissue culture dishes or 75 cm2t-flasks.Either complete medium or hypoxanthine-free medium
37、 can beemployed, with either dialyzed or nondialyzed serum. It isimportant to ensure that the medium employed will allow apopulation doubling time of 12 to 16 h.4.3.3 Besides the normal growth of cells as monolayercultures, alternative methods of subculturing involving suspen-sion (8), unattached (1
38、3), and division arrested (14) cultureshave also been successful. The use of a particular subcultureregimen in the expression period should be substantiated bydata demonstrating the achievement of optimal expression.4.4 Mutant Selection:4.4.1 Conditions for the selection of mutants must bedefined to
39、 ensure that only mutant cells are able to formcolonies and that there is no significant reduction in the abilityof mutant cells to form colonies. In general, cells are plated intissue culture dishes for attached colony growth (11), or in agarfor suspended colony growth (15). An advantage of the for
40、meris that after the colonies are fixed and stained, the plates can beE1262 88 (2018)2counted at a later date. An advantage of the latter is thatmetabolic cooperation between wild type and mutant cells isreduced, allowing selection of a higher cell number per plate.For attached colonies, the cells a
41、re in general cultured for aperiod of 6 to 8 days and the number of colonies counted afterfixing (for example, with 10 % formalin or 70 % methanol),and staining (for example, with 10 % Giemsa or crystal violet).Soft agar colonies are usually counted in situ after a culturingperiod of 10 to 14 days.4
42、.4.2 Reliable selection has been established inhypoxanthine-free medium containing dialyzed serum and 10M 6TG. Fetal bovine serum, newborn bovine serum, or calfserum can be used, providing that the serum has been ad-equately tested and shown to support the desirable character-istics of CHO cells as
43、described here. Dialyzed serum isusually necessary to eliminate the competition between 6TGand purine bases in the serum. It has been found that a selectioncell density of 2 105or fewer cells per 100 mm dish forattached colony growth (14, 16) and 106or fewer cells per 100mm dish (in 30 mLof agar) fo
44、r agar colony growth (15) allowsessentially 100 % recovery of mutant cells.5. Data Presentation5.1 Results from the assay should include the followingexperimental data:5.1.1 Concentrations and solvents used for the test articleand positive controls.5.1.2 Absolute and relative cloning efficiencies (C
45、E) in theconcurrent cytotoxicity assay.5.1.2.1 Absolute CEAbsolute CE equals the number ofcolonies formed divided by the number of cells plated.5.1.2.2 Relative CERelative CE equals CE (treatment)divided by CE (solvent control).5.1.3 Actual number of mutant colonies observed for eachtreatment condit
46、ion.5.1.4 Absolute CE at selection for each treatment condition.5.1.5 Mutant frequency (MF) values, expressed as mutantsper 106cells.5.1.5.1 Mutant Frequency (MF) ValuesMF values equalthe number of mutant colonies divided by the number ofclonable cells.5.1.5.2 Number of Clonable CellsThe number of c
47、lonablecells equals the cells plated multiplied by the absolute CE atselection.6. Criteria for Data Acceptability6.1 Generally, for the data of a given assay to be acceptable,the following criteria should be met:6.1.1 The absolute CE of the negative controls should not beless than 50 %. Absolute CE
48、values lower than 50 % wouldindicate suboptimal culturing conditions for the cells.6.1.2 The mean mutant frequency of the solvent controls ineach experiment should fall within the range from 0 to 20mutants per 106clonable cells.Ahigher mutant frequency maypreclude detection of weak mutagens. Under s
49、uch conditionsdata acceptability should be evaluated on a case-by-case basis.6.1.3 The positive control must induce a statistically signifi-cant response at a magnitude appropriate for the mutagen underthe chosen experimental conditions.6.1.4 The highest test article concentration should, ifpossible, result in a significant cytotoxic response (forexample, 10 % to 30 % survival, where survival is the percentof the treated population that is viable after treatment). This isparticularly important if the response is negative. For noncy-totoxic test articles, the high
